nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP2C19—Sorafenib—thyroid cancer	0.133	0.18	CbGbCtD
Proguanil—CYP1A2—Sorafenib—thyroid cancer	0.123	0.166	CbGbCtD
Proguanil—CYP2C9—Sorafenib—thyroid cancer	0.111	0.15	CbGbCtD
Proguanil—CYP3A4—Vandetanib—thyroid cancer	0.107	0.144	CbGbCtD
Proguanil—CYP2D6—Sorafenib—thyroid cancer	0.101	0.137	CbGbCtD
Proguanil—CYP3A4—Sorafenib—thyroid cancer	0.0643	0.087	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—thyroid cancer	0.0614	0.083	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—thyroid cancer	0.039	0.0528	CbGbCtD
Proguanil—Amylase increased—Vandetanib—thyroid cancer	0.0243	0.107	CcSEcCtD
Proguanil—Amylase increased—Sorafenib—thyroid cancer	0.0164	0.0722	CcSEcCtD
Proguanil—Stomatitis—Vandetanib—thyroid cancer	0.00632	0.0278	CcSEcCtD
Proguanil—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00613	0.027	CcSEcCtD
Proguanil—Mediastinal disorder—Vandetanib—thyroid cancer	0.00524	0.0231	CcSEcCtD
Proguanil—Mental disorder—Vandetanib—thyroid cancer	0.0051	0.0224	CcSEcCtD
Proguanil—Malnutrition—Vandetanib—thyroid cancer	0.00507	0.0223	CcSEcCtD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.00459	0.137	CbGpPWpGaD
Proguanil—Cough—Vandetanib—thyroid cancer	0.00442	0.0194	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00428	0.0188	CcSEcCtD
Proguanil—Stomatitis—Sorafenib—thyroid cancer	0.00426	0.0187	CcSEcCtD
Proguanil—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00414	0.0182	CcSEcCtD
Proguanil—Nervous system disorder—Vandetanib—thyroid cancer	0.00405	0.0178	CcSEcCtD
Proguanil—Skin disorder—Vandetanib—thyroid cancer	0.00402	0.0177	CcSEcCtD
Proguanil—Decreased appetite—Vandetanib—thyroid cancer	0.00359	0.0158	CcSEcCtD
Proguanil—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00357	0.0157	CcSEcCtD
Proguanil—Immune system disorder—Sorafenib—thyroid cancer	0.00355	0.0156	CcSEcCtD
Proguanil—Mediastinal disorder—Sorafenib—thyroid cancer	0.00354	0.0156	CcSEcCtD
Proguanil—Mental disorder—Sorafenib—thyroid cancer	0.00344	0.0151	CcSEcCtD
Proguanil—Malnutrition—Sorafenib—thyroid cancer	0.00342	0.015	CcSEcCtD
Proguanil—Erythema—Sorafenib—thyroid cancer	0.00342	0.015	CcSEcCtD
Proguanil—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00338	0.0149	CcSEcCtD
Proguanil—Abdominal pain—Vandetanib—thyroid cancer	0.00327	0.0144	CcSEcCtD
Proguanil—Body temperature increased—Vandetanib—thyroid cancer	0.00327	0.0144	CcSEcCtD
Proguanil—Cough—Sorafenib—thyroid cancer	0.00298	0.0131	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00289	0.0127	CcSEcCtD
Proguanil—Diarrhoea—Vandetanib—thyroid cancer	0.00283	0.0124	CcSEcCtD
Proguanil—Nervous system disorder—Sorafenib—thyroid cancer	0.00273	0.012	CcSEcCtD
Proguanil—Skin disorder—Sorafenib—thyroid cancer	0.00271	0.0119	CcSEcCtD
Proguanil—Anorexia—Sorafenib—thyroid cancer	0.00266	0.0117	CcSEcCtD
Proguanil—Vomiting—Vandetanib—thyroid cancer	0.00263	0.0116	CcSEcCtD
Proguanil—Rash—Vandetanib—thyroid cancer	0.00261	0.0115	CcSEcCtD
Proguanil—Dermatitis—Vandetanib—thyroid cancer	0.0026	0.0115	CcSEcCtD
Proguanil—Headache—Vandetanib—thyroid cancer	0.00259	0.0114	CcSEcCtD
Proguanil—Nausea—Vandetanib—thyroid cancer	0.00246	0.0108	CcSEcCtD
Proguanil—DHFR—G1/S-Specific Transcription—CDK1—thyroid cancer	0.00244	0.0726	CbGpPWpGaD
Proguanil—Decreased appetite—Sorafenib—thyroid cancer	0.00242	0.0107	CcSEcCtD
Proguanil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00241	0.0106	CcSEcCtD
Proguanil—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00228	0.01	CcSEcCtD
Proguanil—Abdominal pain—Sorafenib—thyroid cancer	0.0022	0.0097	CcSEcCtD
Proguanil—Body temperature increased—Sorafenib—thyroid cancer	0.0022	0.0097	CcSEcCtD
Proguanil—Diarrhoea—Sorafenib—thyroid cancer	0.00191	0.00839	CcSEcCtD
Proguanil—Vomiting—Sorafenib—thyroid cancer	0.00177	0.0078	CcSEcCtD
Proguanil—Rash—Sorafenib—thyroid cancer	0.00176	0.00773	CcSEcCtD
Proguanil—Dermatitis—Sorafenib—thyroid cancer	0.00176	0.00773	CcSEcCtD
Proguanil—Headache—Sorafenib—thyroid cancer	0.00175	0.00768	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—thyroid cancer	0.00172	0.00757	CcSEcCtD
Proguanil—Nausea—Sorafenib—thyroid cancer	0.00166	0.00729	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—thyroid cancer	0.00159	0.00701	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—thyroid cancer	0.00158	0.00693	CcSEcCtD
Proguanil—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00153	0.00672	CcSEcCtD
Proguanil—DHFR—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00148	0.0442	CbGpPWpGaD
Proguanil—Stomatitis—Doxorubicin—thyroid cancer	0.00146	0.00641	CcSEcCtD
Proguanil—DHFR—E2F mediated regulation of DNA replication—CDK1—thyroid cancer	0.00144	0.0427	CbGpPWpGaD
Proguanil—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00141	0.00622	CcSEcCtD
Proguanil—Immune system disorder—Epirubicin—thyroid cancer	0.00131	0.00576	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—thyroid cancer	0.00131	0.00575	CcSEcCtD
Proguanil—Mental disorder—Epirubicin—thyroid cancer	0.00127	0.00559	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—thyroid cancer	0.00126	0.00555	CcSEcCtD
Proguanil—Erythema—Epirubicin—thyroid cancer	0.00126	0.00555	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—thyroid cancer	0.00121	0.00533	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00121	0.00532	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—thyroid cancer	0.00118	0.00517	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—thyroid cancer	0.00117	0.00514	CcSEcCtD
Proguanil—Erythema—Doxorubicin—thyroid cancer	0.00117	0.00514	CcSEcCtD
Proguanil—Cough—Epirubicin—thyroid cancer	0.0011	0.00485	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00107	0.0047	CcSEcCtD
Proguanil—Cough—Doxorubicin—thyroid cancer	0.00102	0.00448	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—thyroid cancer	0.00101	0.00445	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—thyroid cancer	0.001	0.0044	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000988	0.00435	CcSEcCtD
Proguanil—Anorexia—Epirubicin—thyroid cancer	0.000982	0.00432	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—thyroid cancer	0.000935	0.00411	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—thyroid cancer	0.000926	0.00407	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—thyroid cancer	0.000909	0.004	CcSEcCtD
Proguanil—Decreased appetite—Epirubicin—thyroid cancer	0.000896	0.00394	CcSEcCtD
Proguanil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00089	0.00391	CcSEcCtD
Proguanil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000843	0.00371	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—thyroid cancer	0.000829	0.00365	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000823	0.00362	CcSEcCtD
Proguanil—Body temperature increased—Epirubicin—thyroid cancer	0.000815	0.00358	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—thyroid cancer	0.000815	0.00358	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00078	0.00343	CcSEcCtD
Proguanil—DHFR—E2F transcription factor network—CDK1—thyroid cancer	0.000761	0.0226	CbGpPWpGaD
Proguanil—Body temperature increased—Doxorubicin—thyroid cancer	0.000754	0.00332	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—thyroid cancer	0.000754	0.00332	CcSEcCtD
Proguanil—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—thyroid cancer	0.000748	0.0222	CbGpPWpGaD
Proguanil—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00073	0.0217	CbGpPWpGaD
Proguanil—Diarrhoea—Epirubicin—thyroid cancer	0.000705	0.0031	CcSEcCtD
Proguanil—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000666	0.0198	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.000661	0.0197	CbGpPWpGaD
Proguanil—Vomiting—Epirubicin—thyroid cancer	0.000655	0.00288	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—thyroid cancer	0.000652	0.00287	CcSEcCtD
Proguanil—Rash—Epirubicin—thyroid cancer	0.00065	0.00286	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—thyroid cancer	0.000649	0.00286	CcSEcCtD
Proguanil—Headache—Epirubicin—thyroid cancer	0.000646	0.00284	CcSEcCtD
Proguanil—Nausea—Epirubicin—thyroid cancer	0.000612	0.00269	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—thyroid cancer	0.000606	0.00267	CcSEcCtD
Proguanil—Rash—Doxorubicin—thyroid cancer	0.000601	0.00264	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—thyroid cancer	0.000601	0.00264	CcSEcCtD
Proguanil—Headache—Doxorubicin—thyroid cancer	0.000597	0.00263	CcSEcCtD
Proguanil—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000575	0.0171	CbGpPWpGaD
Proguanil—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000569	0.0169	CbGpPWpGaD
Proguanil—Nausea—Doxorubicin—thyroid cancer	0.000566	0.00249	CcSEcCtD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000556	0.0165	CbGpPWpGaD
Proguanil—DHFR—G1/S Transition—CDK1—thyroid cancer	0.000552	0.0164	CbGpPWpGaD
Proguanil—DHFR—Metabolism of nitric oxide—AKT1—thyroid cancer	0.000518	0.0154	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—CDK1—thyroid cancer	0.000465	0.0138	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—CHST14—thyroid cancer	0.000431	0.0128	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000412	0.0123	CbGpPWpGaD
Proguanil—DHFR—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000394	0.0117	CbGpPWpGaD
Proguanil—CYP2E1—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000386	0.0115	CbGpPWpGaD
Proguanil—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000377	0.0112	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—PCM1—thyroid cancer	0.000369	0.011	CbGpPWpGaD
Proguanil—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000344	0.0102	CbGpPWpGaD
Proguanil—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000344	0.0102	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000333	0.00989	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000306	0.0091	CbGpPWpGaD
Proguanil—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.000305	0.00907	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000303	0.00902	CbGpPWpGaD
Proguanil—CYP2E1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000296	0.00879	CbGpPWpGaD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000294	0.00874	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000276	0.0082	CbGpPWpGaD
Proguanil—DHFR—Disease—TRIM24—thyroid cancer	0.000265	0.0079	CbGpPWpGaD
Proguanil—DHFR—Metabolism—MINPP1—thyroid cancer	0.000261	0.00778	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000259	0.00771	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000252	0.00749	CbGpPWpGaD
Proguanil—DHFR—Disease—CHST14—thyroid cancer	0.00025	0.00742	CbGpPWpGaD
Proguanil—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00024	0.00713	CbGpPWpGaD
Proguanil—DHFR—Disease—TRIM33—thyroid cancer	0.000237	0.00704	CbGpPWpGaD
Proguanil—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000228	0.00678	CbGpPWpGaD
Proguanil—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000227	0.00674	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—TP53—thyroid cancer	0.000226	0.00673	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TPR—thyroid cancer	0.000225	0.0067	CbGpPWpGaD
Proguanil—DHFR—Metabolism—NDUFA13—thyroid cancer	0.000222	0.00661	CbGpPWpGaD
Proguanil—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00021	0.00624	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CHST14—thyroid cancer	0.000209	0.00622	CbGpPWpGaD
Proguanil—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000208	0.00618	CbGpPWpGaD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000207	0.00615	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.0002	0.00595	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—CCND1—thyroid cancer	0.000194	0.00577	CbGpPWpGaD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000185	0.0055	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.000182	0.0054	CbGpPWpGaD
Proguanil—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000178	0.00528	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000177	0.00526	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000171	0.00508	CbGpPWpGaD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00017	0.00506	CbGpPWpGaD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000169	0.00501	CbGpPWpGaD
Proguanil—DHFR—Metabolism—HPGD—thyroid cancer	0.000168	0.00501	CbGpPWpGaD
Proguanil—DHFR—Disease—TCF7L1—thyroid cancer	0.000158	0.0047	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDK1—thyroid cancer	0.000153	0.00454	CbGpPWpGaD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000144	0.00428	CbGpPWpGaD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000137	0.00408	CbGpPWpGaD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000136	0.00406	CbGpPWpGaD
Proguanil—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000131	0.0039	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—RXRA—thyroid cancer	0.000127	0.00379	CbGpPWpGaD
Proguanil—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000119	0.00355	CbGpPWpGaD
Proguanil—DHFR—Disease—TPR—thyroid cancer	0.000116	0.00344	CbGpPWpGaD
Proguanil—DHFR—Disease—PRKAR1A—thyroid cancer	0.000114	0.00338	CbGpPWpGaD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000111	0.00331	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TERT—thyroid cancer	0.00011	0.00327	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000109	0.00325	CbGpPWpGaD
Proguanil—DHFR—Disease—MEN1—thyroid cancer	0.000109	0.00323	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000104	0.0031	CbGpPWpGaD
Proguanil—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000102	0.00304	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—RXRA—thyroid cancer	9.82e-05	0.00292	CbGpPWpGaD
Proguanil—DHFR—Metabolism—TPR—thyroid cancer	9.68e-05	0.00288	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PRKAR1A—thyroid cancer	9.52e-05	0.00283	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	9.52e-05	0.00283	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—MINPP1—thyroid cancer	9.35e-05	0.00278	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—RXRA—thyroid cancer	9.03e-05	0.00269	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—RXRA—thyroid cancer	8.95e-05	0.00266	CbGpPWpGaD
Proguanil—DHFR—Disease—CALCA—thyroid cancer	8.65e-05	0.00257	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	8.49e-05	0.00253	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.13e-05	0.00242	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NDUFA13—thyroid cancer	7.95e-05	0.00236	CbGpPWpGaD
Proguanil—DHFR—Disease—CDK1—thyroid cancer	7.83e-05	0.00233	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—RXRA—thyroid cancer	7.65e-05	0.00228	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CHST14—thyroid cancer	7.47e-05	0.00222	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	7.31e-05	0.00217	CbGpPWpGaD
Proguanil—DHFR—Metabolism—SLC5A5—thyroid cancer	7.24e-05	0.00216	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—MINPP1—thyroid cancer	7.21e-05	0.00215	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CCND1—thyroid cancer	7.11e-05	0.00212	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—MINPP1—thyroid cancer	6.63e-05	0.00197	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—MINPP1—thyroid cancer	6.58e-05	0.00196	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CCND1—thyroid cancer	6.36e-05	0.00189	CbGpPWpGaD
Proguanil—DHFR—Disease—NRG1—thyroid cancer	6.29e-05	0.00187	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	6.21e-05	0.00185	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NDUFA13—thyroid cancer	6.13e-05	0.00182	CbGpPWpGaD
Proguanil—DHFR—Metabolism—RXRA—thyroid cancer	6.09e-05	0.00181	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—HPGD—thyroid cancer	6.02e-05	0.00179	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.9e-05	0.00176	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CHST14—thyroid cancer	5.77e-05	0.00172	CbGpPWpGaD
Proguanil—DHFR—Disease—TERT—thyroid cancer	5.64e-05	0.00168	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NDUFA13—thyroid cancer	5.64e-05	0.00168	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MINPP1—thyroid cancer	5.62e-05	0.00167	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NDUFA13—thyroid cancer	5.59e-05	0.00166	CbGpPWpGaD
Proguanil—DHFR—Disease—HIF1A—thyroid cancer	5.4e-05	0.00161	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CHST14—thyroid cancer	5.3e-05	0.00158	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CHST14—thyroid cancer	5.26e-05	0.00156	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NDUFA13—thyroid cancer	4.78e-05	0.00142	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—HPGD—thyroid cancer	4.65e-05	0.00138	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CHST14—thyroid cancer	4.49e-05	0.00134	CbGpPWpGaD
Proguanil—DHFR—Disease—BRAF—thyroid cancer	4.47e-05	0.00133	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.34e-05	0.00129	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—HPGD—thyroid cancer	4.27e-05	0.00127	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—HPGD—thyroid cancer	4.24e-05	0.00126	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—thyroid cancer	4.19e-05	0.00125	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PPARG—thyroid cancer	3.84e-05	0.00114	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.77e-05	0.00112	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.69e-05	0.0011	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HPGD—thyroid cancer	3.62e-05	0.00108	CbGpPWpGaD
Proguanil—DHFR—Disease—PTGS2—thyroid cancer	3.61e-05	0.00107	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CHST14—thyroid cancer	3.47e-05	0.00103	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—TPR—thyroid cancer	3.46e-05	0.00103	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.44e-05	0.00102	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	3.4e-05	0.00101	CbGpPWpGaD
Proguanil—DHFR—Disease—PTEN—thyroid cancer	3.15e-05	0.000936	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTGS2—thyroid cancer	3.02e-05	0.000899	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.94e-05	0.000874	CbGpPWpGaD
Proguanil—DHFR—Disease—NRAS—thyroid cancer	2.81e-05	0.000836	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HPGD—thyroid cancer	2.79e-05	0.000831	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TPR—thyroid cancer	2.67e-05	0.000794	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTEN—thyroid cancer	2.64e-05	0.000784	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.63e-05	0.000781	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SLC5A5—thyroid cancer	2.59e-05	0.00077	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TPR—thyroid cancer	2.46e-05	0.00073	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TPR—thyroid cancer	2.43e-05	0.000724	CbGpPWpGaD
Proguanil—DHFR—Disease—KRAS—thyroid cancer	2.42e-05	0.000719	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.42e-05	0.000719	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.39e-05	0.000712	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.38e-05	0.000708	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—RXRA—thyroid cancer	2.18e-05	0.000647	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.17e-05	0.000646	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TPR—thyroid cancer	2.08e-05	0.000619	CbGpPWpGaD
Proguanil—DHFR—Disease—HRAS—thyroid cancer	2.05e-05	0.000611	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.05e-05	0.000609	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2e-05	0.000594	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.87e-05	0.000557	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.85e-05	0.000552	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.84e-05	0.000547	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.82e-05	0.000542	CbGpPWpGaD
Proguanil—DHFR—Disease—AKT1—thyroid cancer	1.81e-05	0.00054	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.71e-05	0.000508	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—RXRA—thyroid cancer	1.68e-05	0.000499	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.63e-05	0.000486	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TPR—thyroid cancer	1.61e-05	0.000478	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.58e-05	0.00047	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.56e-05	0.000463	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—RXRA—thyroid cancer	1.54e-05	0.000459	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—RXRA—thyroid cancer	1.53e-05	0.000455	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKT1—thyroid cancer	1.52e-05	0.000452	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.49e-05	0.000443	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.46e-05	0.000434	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PPARG—thyroid cancer	1.37e-05	0.000409	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—RXRA—thyroid cancer	1.31e-05	0.000389	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.27e-05	0.000379	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.2e-05	0.000357	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.08e-05	0.000322	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPARG—thyroid cancer	1.06e-05	0.000315	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—RXRA—thyroid cancer	1.01e-05	0.0003	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPARG—thyroid cancer	9.75e-06	0.00029	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPARG—thyroid cancer	9.67e-06	0.000288	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—thyroid cancer	9.43e-06	0.00028	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTGS2—thyroid cancer	8.34e-06	0.000248	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPARG—thyroid cancer	8.26e-06	0.000246	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.67e-06	0.000228	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS2—thyroid cancer	7.6e-06	0.000226	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—thyroid cancer	7.27e-06	0.000216	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—thyroid cancer	6.69e-06	0.000199	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—thyroid cancer	6.63e-06	0.000197	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS2—thyroid cancer	6.5e-06	0.000193	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPARG—thyroid cancer	6.37e-06	0.00019	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—thyroid cancer	5.67e-06	0.000169	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKT1—thyroid cancer	5.43e-06	0.000162	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.01e-06	0.000149	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—thyroid cancer	4.37e-06	0.00013	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKT1—thyroid cancer	4.19e-06	0.000125	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKT1—thyroid cancer	3.85e-06	0.000115	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKT1—thyroid cancer	3.82e-06	0.000114	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKT1—thyroid cancer	3.27e-06	9.71e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKT1—thyroid cancer	2.52e-06	7.5e-05	CbGpPWpGaD
